TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 57 filers reported holding TALARIS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,270 | -69.3% | 1,164 | -66.7% | 0.00% | – |
| Q2 2023 | $10,636 | +16263.1% | 3,499 | -89.8% | 0.00% | – |
| Q1 2023 | $65 | +85.7% | 34,422 | +0.6% | 0.00% | – |
| Q4 2022 | $35 | -100.0% | 34,222 | +1.7% | 0.00% | – |
| Q3 2022 | $88,000 | -38.5% | 33,647 | +6.1% | 0.00% | – |
| Q2 2022 | $143,000 | -2.7% | 31,713 | +112.3% | 0.00% | – |
| Q1 2022 | $147,000 | -32.9% | 14,941 | +4.5% | 0.00% | – |
| Q4 2021 | $219,000 | – | 14,304 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $7,713,000 | 11.20% |
| Aisling Capital Management LP | 175,000 | $460,000 | 0.30% |
| Artal Group S.A. | 2,064,262 | $5,429,000 | 0.23% |
| Cormorant Asset Management, LP | 900,649 | $2,369,000 | 0.17% |
| Eventide Asset Management | 1,561,092 | $4,106,000 | 0.08% |
| Blackstone Inc. | 8,089,315 | $21,275 | 0.08% |
| Logos Global Management LP | 197,913 | $521,000 | 0.06% |
| Values First Advisors, Inc. | 30,715 | $81,000 | 0.06% |
| VIKING GLOBAL INVESTORS LP | 3,289,617 | $8,652,000 | 0.04% |
| CAAS CAPITAL MANAGEMENT LP | 297,707 | $783,000 | 0.04% |